|
|
||||||||
1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants
1 Dept of Molecular Epidemiology/Cancer Registry, University of Zurich, and 2 Dept of Pneumology, University Hospital of Zurich, Zurich, Switzerland.
CORRESPONDENCE: N. M. Probst-Hensch, Dept of Molecular Epidemiology/Cancer Registry, University of Zurich, Vogelsangstrasse 10, 8091 Zurich, Switzerland. Fax: 41 442555636. E-mail: nicole.probst{at}usz.ch
Keywords:
1-Antitrypsin,
1-antitrypsin deficiency, geneenvironment interaction, occupational disorder, occupational exposure, passive smoking
Received: February 24, 2005
Accepted June 9, 2005
Chronic obstructive pulmonary disease (COPD) is a prevalent and preventable disease associated with high morbidity and mortality. Severe and intermediate
In this study, a MEDLINE search was carried out for studies investigating the combined effect of environmental inhalants (occupation and passive smoking) and AAT deficiency in the lung. A total of 18 studies using established methods for the assessment of AAT deficiency were included in this review.
Occupational exposures and passive smoking affected lung function decline or prevalence of respiratory symptoms in four out of five studies investigating subjects with severe AAT deficiency, and in eight out of 13 studies with a focus on intermediate AAT deficiency. While study designs mostly prohibited formal assessment of effect modification, an interaction between intermediate AAT deficiency and passive smoking was identified in two studies with children. Additional study limitations included small sample size, poor adjustment for confounding and misclassification of environmental exposure as well as AAT activity.
In conclusion, population-based epidemiological studies with associated biobanks are needed to identify geneenvironment interactions and population subgroups susceptible to
1-antitrypsin (AAT) deficiency (serum levels <11 and 1120 µmol·L1, respectively) increase the risk of COPD in active smokers. However, little is known about the interaction of severe and intermediate AAT deficiency with modifiable COPD risk factors other than active smoking.
1-antitrypsin deficiency.
This article has been cited by other articles:
![]() |
D. M.v. Leeuwen, E. v. Agen, R. W.H. Gottschalk, R. Vlietinck, M. Gielen, M. H.M.v. Herwijnen, L. M. Maas, J. C.S. Kleinjans, and J. H.M.v. Delft Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs Carcinogenesis, March 1, 2007; 28(3): 691 - 697. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |